Phase 3 Dermatitis Clinical Trials
22 recruitingPhase 3
What is a Phase 3 trial?
Phase 3 trials compare the new treatment against the current standard of care in large groups, often hundreds to thousands of participants. Successful Phase 3 results are typically required for regulatory approval.
Showing 1–20 of 22 trials
Recruiting
Phase 3
A Study to Investigate Safety and Efficacy of Tapinarof Cream, 1% in Participants Ages 3 Months to < 24 Months With Atopic Dermatitis
Atopic Dermatitis
Organon and Co180 enrolled47 locationsNCT07265479
Recruiting
Phase 3
A Study of Upadacitinib in Adult Participants With Moderate-to-Severe Atopic Dermatitis and Inadequate Response to Dupilumab
Atopic Dermatitis
AbbVie200 enrolled126 locationsNCT06389136
Recruiting
Phase 3
A Study to Evaluate the Efficacy and Safety of Subcutaneous Amlitelimab on Background Topical Corticosteroids Therapy in Participants Aged 12 Years and Older With Moderate-to-severe AD Who Have Had an Inadequate Response to Prior Biologic Therapy or an Oral JAK Inhibitor
Dermatitis Atopic
Sanofi636 enrolled147 locationsNCT06241118
Recruiting
Phase 3
A Long-term Study of the Medicine Called Abrocitinib in Children Aged 2 Years and Older With Moderate to Severe Eczema
Atopic Dermatitis
Pfizer500 enrolled31 locationsNCT06807281
Recruiting
Phase 3
A Study to Assess Adverse Events and Change in Disease Activity Comparing Oral Upadacitinib to Subcutaneous Dupilumab in Children From 2 to Less Than 12 Years of Age With Moderate to Severe Atopic Dermatitis
Atopic Dermatitis
AbbVie675 enrolled148 locationsNCT06461897
Recruiting
Phase 3
A Study of SHR-1819 Injection in Adolescents With Severe Atopic Dermatitis
Adolescents With Moderate-to-severe Atopic Dermatitis
Guangdong Hengrui Pharmaceutical Co., Ltd201 enrolled2 locationsNCT07309055
Recruiting
Phase 2Phase 3
Topical Periplaneta Americana-Derived Meilian Fuxin Liquid for Radiation Dermatitis
Radiation induced dermatitis
West China Hospital60 enrolled2 locationsNCT07353671
Recruiting
Phase 3
A Trial to Evaluate the Efficacy and Safety of Tralokinumab in Combination With Topical Corticosteroids in Children and Infants With Moderate-to-severe Atopic Dermatitis
Atopic Dermatitis
LEO Pharma195 enrolled72 locationsNCT06311682
Recruiting
Phase 3
A Study to Assess the Efficacy and Safety of Ruxolitinib Cream in Children and Adolescents (6 to <18 Years Old) With Moderate Atopic Dermatitis
Atopic Dermatitis
Incyte Corporation240 enrolled96 locationsNCT06832618
Recruiting
Phase 3
Evaluation of 611 in Chinese Adolescents With Moderate to Severe Atopic Dermatitis
Dermatitis Atopic
Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd.180 enrolled3 locationsNCT07042126
Recruiting
Phase 3
ICP-332 in Subjects With Moderate to Severe Atopic Dermatitis
Atopic Dermatitis
Beijing InnoCare Pharma Tech Co., Ltd.552 enrolled62 locationsNCT06775860
Recruiting
Phase 3
Efficacy and Safety of Methotrexate Versus Placebo in Adults With Atopic Dermatitis.
Moderate-to-severe Atopic Dermatitis
medac GmbH277 enrolled30 locationsNCT06239311
Recruiting
Phase 3
Efficacy and Safety Study of QLM3003 Ointment in Participants With Mild or Moderate Atopic Dermatitis
Atopic Dermatitis
Qilu Pharmaceutical Co., Ltd.360 enrolled1 locationNCT06880276
Recruiting
Phase 3
Modulating the Skin Microbiome to Prevent Radiation Dermatitis in Breast Cancer
Breast CancerSkin MicrobiomeRadiation Dermatitis
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University326 enrolled1 locationNCT07066280
Recruiting
Phase 3
A Study to Assess the Efficacy and Safety of PG-011 Gel in Adolescents and Adults With Atopic Dermatitis
Atopic Dermatitis
Prime Gene Therapeutics Co., Ltd.472 enrolled1 locationNCT06587685
Recruiting
Phase 3
Topical Betamethasone Versus Moisturizer in Preventing Radiation Dermatitis in Large-Breasted Patients Treated in the Prone Position
Breast CancerRadiation Dermatitis
Sunnybrook Health Sciences Centre276 enrolled1 locationNCT06915857
Recruiting
Phase 2Phase 3
Herbal Ointment in Treating Atopic Dermatitis Topically
atopic dermatitis (eczema)Atopic DermatitisAtopic Dermatitis (AD)+4 more
En Chu Kong Hospital66 enrolled1 locationNCT06850311
Recruiting
Phase 3
Phase III Clinical Study of VC005 Tablets in Adult Patients With Moderate to Severe Atopic Dermatitis
Moderate-to-severe Atopic Dermatitis
Jiangsu vcare pharmaceutical technology co., LTD480 enrolled1 locationNCT06723080
Recruiting
Phase 3
A Phase III Study to Evaluate the Efficacy and Safety of AK120 in Patients With Moderate to Severe Atopic Dermatitis
Atopic Dermatitis
Akeso420 enrolled59 locationsNCT06383468
Completed
Phase 3
Efficacy of Incontinence Associated Dermatitis Interventions for Critically Ill Patients in Intensive Care: the Distinct Pilot Randomised Control Trial.
Incontinence Associated Dermatitis (IAD)
Queensland University of Technology30 enrolled1 locationACTRN12617000537358